Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Inventory (2016 - 2025)

InspireMD filings provide 14 years of Inventory readings, the most recent being $3.4 million for Q4 2025.

  • On a quarterly basis, Inventory rose 32.14% to $3.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.4 million, a 32.14% increase, with the full-year FY2025 number at $3.4 million, up 32.14% from a year prior.
  • Inventory hit $3.4 million in Q4 2025 for InspireMD, down from $3.6 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $3.6 million in Q3 2025 to a low of $1.1 million in Q3 2021.
  • Median Inventory over the past 5 years was $1.8 million (2023), compared with a mean of $2.0 million.
  • Biggest five-year swings in Inventory: decreased 19.22% in 2021 and later soared 47.53% in 2025.
  • InspireMD's Inventory stood at $1.1 million in 2021, then surged by 41.82% to $1.6 million in 2022, then rose by 29.92% to $2.1 million in 2023, then grew by 22.03% to $2.6 million in 2024, then surged by 32.14% to $3.4 million in 2025.
  • The last three reported values for Inventory were $3.4 million (Q4 2025), $3.6 million (Q3 2025), and $3.1 million (Q2 2025) per Business Quant data.